18-05-2025
Kepler Capital Reaffirms Their Buy Rating on Affluent Medical SA (0JZ)
In a report released on May 16, Nicolas Pauillac from Kepler Capital maintained a Buy rating on Affluent Medical SA (0JZ – Research Report), with a price target of €3.80. The company's shares closed last Friday at €1.42.
Confident Investing Starts Here:
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Pauillac is ranked #1649 out of 9519 analysts.
Affluent Medical SA has an analyst consensus of Moderate Buy, with a price target consensus of €3.80.
